Superficial Cervical Plexus Block With Either Clavipectoral Fascial Plane Block or Interscalene Brachial Block for Clavicle Surgeries Anesthesia

NCT06831604 | Recruiting

• 1 other identifier: 36265MD331/12/24
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate and compare the efficacy and safety of ultrasound guided superficial cervical plexus block (SCPB) with either clavipectoral fascial plane block (CPB) or interscalene brachial plexus block (ISBP) as an anesthetic technique for clavicle surgeries.

Conditions

Ultrasound; Superficial Cervical Plexus Block; Clavipectoral Fascial Plane Block; Interscalene Brachial Block; Clavicle Surgeries

Outcome Measures

Primary Outcomes (1)

• Success rate

  The block will be considered successful when complete sensory block is achieved within 45 min after injection of the study drug and inadequate block will be converted to general anesthesia and excluded from the study.

  Intraoperatively

Secondary Outcomes (4)

• First request of the rescue analgesia

  24 hours postoperatively

• Total morphine consumption

  24 hours postoperatively

• Degree of patient satisfaction

  24 hours postoperatively

• Incidence of Complications

  24 hours postoperatively

Study Arms (2)

Group I

EXPERIMENTAL

Patients will receive Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB).

Drug: Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB)

Group II

EXPERIMENTAL

Patients will receive Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP).

Drug: Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Interventions

Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB) DRUG

Patients will receive Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB).

Also known as: Group I

Group I

Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP) DRUG

Patients will receive Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Also known as: Group II

Group II

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Aged 18 to 65 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I, II.
• Patients with unilateral clavicular fractures undergo elective internal fixation of clavicle fractures.

You may not qualify if:

• Coagulopathy.
• Patients with infection at block site.
• Allergy to local anesthetics.
• Patient with morbid obesity (body mass index \>35 kg/m2).
• Pre-existing neurological disease.
• Difficult communication.

Sponsors & Collaborators

• Tanta University: lead

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

RECRUITING

MeSH Terms

Interventions

small cardioactive peptide B

Central Study Contacts

Ahmed M Aboeldahab, Master

CONTACT

00201069784512; ahmed.aboeldahab1422@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Study Record Dates

• First Submitted: February 8, 2025
• First Posted: February 18, 2025
• Study Start: February 20, 2025
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): July 1, 2026
• Last Updated: March 11, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After the end of study for one year.
• Access Criteria: The data will be available upon a reasonable request from the corresponding author.

Locations

EG (1)